These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2703758)

  • 21. Encephalopathic effect of phenol in rats.
    Windus-Podehl G; Lyftogt C; Zieve L; Brunner G
    J Lab Clin Med; 1983 Apr; 101(4):586-92. PubMed ID: 6833829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aging is associated with reduced liver regeneration and diminished thymidine kinase mRNA content and enzyme activity in the rat.
    Beyer HS; Sherman R; Zieve L
    J Lab Clin Med; 1991 Feb; 117(2):101-8. PubMed ID: 1704406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in endogenous prostaglandin levels during D-galactosamine-induced liver injury.
    Koyama Y; Imoto M; Tanaka M; Fukuda Y; Satake T; Ozawa T
    Biochem Int; 1989 Aug; 19(2):421-8. PubMed ID: 2818605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ameliorative effect of an urinary preparation on acetaminophen and D-galactosamine induced hepatotoxicity in rats.
    Lai TY; Wu YW; Lin WC
    Am J Chin Med; 1999; 27(1):73-81. PubMed ID: 10354819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality.
    Chanda S; Mangipudy RS; Warbritton A; Bucci TJ; Mehendale HM
    Hepatology; 1995 Feb; 21(2):477-86. PubMed ID: 7843722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the effect of liver cytosol on experimental acute hepatic failure in the rat].
    Ha TZ
    Zhonghua Yi Xue Za Zhi; 1989 May; 69(5):267-70, 18. PubMed ID: 2804738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of galactosamine-induced hepatic failure upon blood-brain barrier permeability.
    Lo WD; Ennis SR; Goldstein GW; McNeely DL; Betz AL
    Hepatology; 1987; 7(3):452-6. PubMed ID: 3570156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An increase in cerebral benzodiazepine receptors induced by a subacute administration of ammonia, mercaptans and short-chain fatty acids in rats.
    Baraldi M; Zeneroli ML; Ventura E; Vezzelli C
    Clin Sci (Lond); 1987 Dec; 73(6):669-71. PubMed ID: 2826071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An animal model of fulminant hepatic failure in the rat.
    Watanabe A; Higashi T; Nagashima H
    Acta Med Okayama; 1979 Dec; 33(6):443-50. PubMed ID: 161469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Homologous plasma cross-circulation on galactosamine induced hepatic failure rats].
    Ouchi K; Koyama K; Asanuma Y; Okabe K; Sato T
    Nihon Geka Gakkai Zasshi; 1984 May; 85(5):452-6. PubMed ID: 6749113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Decreased dopaminergic activity in hepatic encephalopathy in rats with galactosamine-induced acute liver failure].
    Yamada A; Takeuchi H; Miki H; Touge T; Nishioka M
    No To Shinkei; 1992 Feb; 44(2):103-9. PubMed ID: 1567728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of ammonia and octanoic acid on liver regeneration in the rat.
    Ellis WR; Chu PK; Murray-Lyon IM
    Clin Sci (Lond); 1979 Jan; 56(1):95-7. PubMed ID: 477188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of single or consecutive administration of T-2588 on hepatic-injured male rats].
    Shimotori T; Shibata T; Nakagawa S; Sato S; Nagai A; Yoneda T
    Jpn J Antibiot; 1986 Sep; 39(9):2307-23. PubMed ID: 3795480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc content in liver of experimental fulminant hepatic failure rat.
    Kawanishi H; Nishiki M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1983 Sep; 32(3):305-9. PubMed ID: 6358141
    [No Abstract]   [Full Text] [Related]  

  • 35. An anesthetized model of lethal canine galactosamine fulminant hepatic failure.
    Sielaff TD; Hu MY; Rollins MD; Bloomer JR; Amiot B; Hu WS; Cerra FB
    Hepatology; 1995 Mar; 21(3):796-804. PubMed ID: 7875678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protective effect of hepatic stimulator substance against experimental acute liver failure in mice].
    An W; Mei MH
    Sheng Li Xue Bao; 1991 Oct; 43(5):415-27. PubMed ID: 1796305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems.
    Dixit V; Chang TM
    ASAIO Trans; 1990; 36(1):21-7. PubMed ID: 2306387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of hepatic stimulatory substance, isolated from regenerating hepatic cytosol, and 50,000 and 300,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with D-galactosamine.
    Francavilla A; DiLeo A; Polimeno L; Gavaler J; Pellicci R; Todo S; Kam I; Prelich J; Makowka L; Starzl TE
    Hepatology; 1986; 6(6):1346-51. PubMed ID: 3539743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regeneration after in situ flushing of partially hepatectomised rat livers.
    Bolitho DG; Engelbrecht GH; Lotz Z; Tyler M; McLeod H; Hickman R
    S Afr J Surg; 1995 Jun; 33(2):78-81. PubMed ID: 8545730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cyclic AMP- and ATP-mediated stimulation of DNA synthesis following partial hepatectomy by prostaglandin-E1 in D-galactosamine injured liver].
    Shimura T; Miyazaki M; Koshikawa H; Takahashi O; Sugasawa H; Fujimoto S; Okui K
    Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1618-24. PubMed ID: 3003557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.